Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis

被引:79
|
作者
Okamura, Daryl M. [1 ]
Pasichnyk, Katie
Lopez-Guisa, Jesus M.
Collins, Sarah
Hsu, Daniel K. [2 ]
Liu, Fu-Tong [2 ]
Eddy, Allison A.
机构
[1] Univ Washington, Seattle Childrens Res Inst, Div Nephrol, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Calif Davis, Med Ctr, Div Res Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
chronic kidney disease; nephron loss; matrix degradation; tubular apoptosis; defective tissue remodeling; GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; EXPERIMENTAL MURINE SCHISTOSOMIASIS; INTRACELLULAR COLLAGEN DEGRADATION; INTERSTITIAL FIBROSIS; PICROSIRIUS-POLARIZATION; OBSTRUCTIVE NEPHROPATHY; CELL-GROWTH; APOPTOSIS; RECEPTOR; INJURY;
D O I
10.1152/ajprenal.00326.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu F, Eddy AA. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300: F245-F253, 2011. First published October 20, 2010; doi: 10.1152/ajprenal.00326.2010.-Renal tubular cell apoptosis is a critical detrimental event that leads to chronic kidney injury in association with renal fibrosis. The present study was designed to investigate the role of galectin-3 (Gal-3), an important regulator of multiple apoptotic pathways, in chronic kidney disease induced by unilateral ureteral obstruction (UUO). After UUO, Gal-3 expression significantly increased compared with basal levels reaching a peak increase of 95-fold by day 7. Upregulated Gal-3 is predominantly tubular at early time points after UUO but shifts to interstitial cells as the injury progresses. On day 14, there was a significant increase in TdT-mediated dUTP nick end labeling-positive cells (129%) and cytochrome c release (29%), and a decrease in BrdU-positive cells (62%) in Gal-3-deficient compared with wild-type mice. The degree of renal damage was more extensive in Gal-3-deficient mice at days 14 and 21, 35 and 21% increase in total collagen, respectively. Despite more severe fibrosis, myofibroblasts were significantly decreased by 58% on day 14 in the Gal-3-deficient compared with wild-type mice. There was also a corresponding 80% decrease in extracellular matrix synthesis in Gal-3-deficient compared with wild-type mice. Endo180 is a recently recognized receptor for intracellular collagen degradation that is expressed by interstitial cells during renal fibrogenesis. Endo180 expression was significantly decreased by greater than 50% in Gal-3-deficient compared with wild-type mice. Taken together, these results suggested that Gal-3 not only protects renal tubules from chronic injury by limiting apoptosis but that it may lead to enhanced matrix remodeling and fibrosis attenuation.
引用
收藏
页码:F245 / F253
页数:9
相关论文
共 50 条
  • [1] Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy
    Rubis, Pawel
    Holcman, Katarzyna
    Dziewiecka, Ewa
    Wisniowska-Smialek, Sylwia
    Karabinowska, Aleksandra
    Szymonowicz, Maria
    Khachatryan, Lusine
    Wypasek, Ewa
    Garlitski, Ann
    Gackowski, Andrzej
    Podolec, Piotr
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 30 (03): : 245 - 253
  • [2] Regulation of cellular adhesion to extracellular matrix proteins by galectin-3
    Ochieng, J
    Leite-Browning, ML
    Warfield, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (03) : 788 - 791
  • [3] Extracellular functions of galectin-3
    Ochieng, J
    Furtak, V
    Lukyanov, P
    GLYCOCONJUGATE JOURNAL, 2002, 19 (7-9) : 527 - 535
  • [4] Extracellular functions of galectin-3
    Josiah Ochieng
    Vyacheslav Furtak
    Pavel Lukyanov
    Glycoconjugate Journal, 2002, 19 : 527 - 535
  • [5] Urinary Galectin-3 Is a Potential Novel Biomarker of Renal Fibrosis
    Willrich, Maria Alice V.
    Gray, Amber V.
    Wang, Xiangling
    Rule, Andrew D.
    Lieske, John C.
    Saenger, Amy K.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (03) : 422 - 422
  • [6] Galectin-3 Modulates Experimental Colitis
    Lippert, Elisabeth
    Stieber-Gunckel, Manuela
    Dunger, Nadja
    Falk, Werner
    Obermeier, Florian
    Kunst, Claudia
    DIGESTION, 2015, 92 (01) : 45 - 53
  • [7] Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
    Henderson, Neil C.
    Mackinnon, Alison C.
    Farnworth, Sarah L.
    Kipari, Tiina
    Haslett, Christopher
    Iredale, John P.
    Liu, Fu-Tong
    Hughes, Jeremy
    Sethi, Tariq
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (02): : 288 - 298
  • [8] Galectin-3, Cardiac Function, and Fibrosis
    Meijers, Wouter C.
    Lopez-Andres, Natalia
    de Boer, Rudolf A.
    AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (08): : 2232 - 2234
  • [9] Galectin-3 regulates liver fibrosis
    Henderson, NC
    Poirier, F
    Iredale, JP
    Simpson, KJ
    Sethi, T
    JOURNAL OF HEPATOLOGY, 2005, 42 : 12 - 12
  • [10] Galectin-3 in cardiac remodeling and heart failure
    De Boer R.A.
    Yu L.
    Van Veldhuisen D.J.
    Current Heart Failure Reports, 2010, 7 (1) : 1 - 8